News - Page 9
Development of iPSC-derived conducting airways & application to toxicity testing
The in3 project is funded by the EU’s Marie Skłodowska-Curie Action – Innovative Training Network (MSCA-ITN), part of a 3-year project to develop novel ways to assess toxicity for…
Read update
NB to develop a new skin metabolism model using iPSC derived skin cells
Working with academics Prof Mark Birch-Machin and Dr Peter Hanson from the Institute of Cellular Medicine, Newcells is using its expertise in cellular reprogramming and differentiation of iPSCs to…
Read update
NB completes a licensing agreement with ID Pharma Co. Ltd for induced pluripotent stem cell technologies
The agreement will enable Newcells to develop, manufacture, distribute products and offer services to customers based on reprogramming cells using the CytioTuneTM-iPS kit. Prof Lyle Armstrong, CSO of Newcells Biotech,…
Read update
NB completes a licensing agreement with iPS Academia Japan, Inc. for induced pluripotent stem cell technologies
The agreement will enable Newcells to develop, manufacture, distribute products and offer services to customers in the pharmaceutical, biotechnology and academic sectors in Europe. Dr Mike Nicholds CEO of Newcells…
Read update
